<DOC>
	<DOCNO>NCT01757301</DOCNO>
	<brief_summary>Pain common presenting symptom medical outpatient , depression anxiety two common mental disorder . All three condition often inadequately treated result substantial disability , reduce health-related quality life , increase health care cost utilization . Additionally , pain , anxiety , depression ( PAD ) frequently comorbid one another reciprocal negative effect treatment response additive effect adverse health outcome . The PAD triad especially burdensome Veterans , high prevalence chronic pain , depression , PTSD , anxiety disorder . The Comprehensive v . Assisted Management Mood Physical Symptoms ( CAMMPS ) study randomize comparative effectiveness trial design test relative effectiveness lower-resource vs. higher-resource enhancement usual primary care management Veterans suffer pain plus comorbid anxiety and/or depression .</brief_summary>
	<brief_title>Comprehensive v . Assisted Management Mood Pain Symptoms ( CAMMPS ) Trial</brief_title>
	<detailed_description>The Comprehensive v . Assisted Management Mood Physical Symptoms ( CAMMPS ) study randomize comparative effectiveness trial design test relative effectiveness lower-resource vs. higher-resource enhancement usual primary care management Veterans suffer pain plus comorbid anxiety and/or depression . This single-site study enrol Veterans . Patients follow primary care clinic Roudebush VAMC eligible clinically significant level pain plus comorbid anxiety and/or depression . A total 300 eligible patient provide informed consent randomize one two treatment arm . One group ( n=150 ) receive assist symptom management ( ASM ) consist automate symptom monitoring interactive voice record Internet prompt pain self-management guide symptom level . The second group ( n=150 ) receive comprehensive symptom management ( CSM ) combine ASM optimize medication management deliver nurse-physician specialist team facilitate mental health care . This team partner VA primary care physicians psychologist embed primary care monitor adjust treatment use evidence-based analgesic antidepressant algorithm , reinforce self-management , care coordination . The investigator postulate although intervention likely beneficial , CSM superior ASM . In short , trial compare : 1 ) usual care plus assisted symptom management ( ASM ) vs. 2 ) usual care plus ASM plus optimized medication care management facilitate mental health care ( CSM ) . Outcomes assessed baseline , 1 , 3 , 6 , 12 month . The primary outcome composite pain-anxiety-depression severity score . Secondary outcome include individual pain , anxiety , depression score ; functional status health-related quality life ; treatment satisfaction ; perceive barrier facilitator CSM ASM intervention . The rationale ASM preliminary evidence effectiveness lower use resource . The rationale CSM addition optimize medication management , facilitate mental health care , coordination primary care physicians/Patient Aligned Care Teams ( PACTs ) psychologists PAD symptom substantially enhance benefit ASM .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pain</mesh_term>
	<criteria>Individuals must patient Richard L. Roudebush VAMC Indianapolis , Indiana Individuals eligible pain plus comorbid anxiety and/or depression . Pain must : musculoskeletal , either localize ( arm , leg , back , neck ) widespread ( fibromyalgia ) persist 3 month longer despite trial least one analgesic medication least moderate severity , define Brief Pain Inventory average severity score 5 great Depression must least moderate severity , define PHQ8 score 10 great either depressed mood and/or anhedonia endorse , OR Anxiety must least moderate severity , define GAD7 score 10 great , OR A composite mood score ( anxiety depression ) sufficient severity , define GAD7 + PHQ8 score 12 great . Individuals exclude : speak English moderately severe cognitive impairment define validated 6item cognitive screener schizophrenia , bipolar disorder psychosis severe mental illness and/or high risk suicide pregnant anticipate life expectancy le 12 month . Patients antidepressant still meet PHQ9 and/or GAD7 entry criterion clinical depression and/or anxiety may still eligible adequate dose antidepressant adequate duration time ( i.e. , 12 week ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pain</keyword>
	<keyword>Depression</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Musculoskeletal</keyword>
	<keyword>Fibromyalgia</keyword>
</DOC>